COMMUNIQUÉS West-GlobeNewswire

Research Update
07/11/2025
Scancell Holdings plc Scancell holds oral presentation of positive Phase 2 data on Immunobody ® iSCIB1+ in late-stage melanoma at SITC 2025 Data from SCOPE trial show a potential new benchmark i n efficacy, durability, [...]
Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE
07/11/2025
SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the “Boundless Care, New Beginnings” [...]
Major shareholder announcement
07/11/2025
Please read the full announcement in PDF Attachments 2025_47_Major_Shareholders_Announcement Novozymes B 05 November 2025_Final
React19 Launches “This Is Our Shot” Campaign as U.S. Vaccine Injury Victims Continue to Go Unheard and Uncompensated
07/11/2025
Patient-led nonprofit has already distributed $1.4 million in aid, challenging the federal government’s injury program SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- As the federal government’s Countermeasures Injury [...]
Built for Peace of Mind: How HomeInherit Serves Seniors
07/11/2025
HomeInherit develops a senior-first home equity model built on clarity, safety, and community trust. HomeInherit Logo SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- HomeInherit, a senior-focused financial services [...]
Treace Medical Concepts Reports Third Quarter 2025 Financial Results
06/11/2025
PONTE VEDRA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
06/11/2025
Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related disorders Initiated Good Laboratory Practice (GLP) toxicology studies for CMP- [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025
06/11/2025
Conference Call Scheduled for Friday, November 14, 2025 at 9:00 AM ET PORTLAND, Maine, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company [...]
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
06/11/2025
MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
06/11/2025
CONSHOHOCKEN, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Seer Reports Third Quarter 2025 Financial Results
06/11/2025
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended [...]
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
06/11/2025
Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activities to be completed in the fourth quarter 2025 SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Pliant [...]
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
06/11/2025
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer – – Expects to report an update from [...]
LB Pharmaceuticals Announces Presentation at the Stifel 2025 Healthcare Conference
06/11/2025
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced that Heather Turner, Chief Executive Officer, will present at the Stifel 2025 [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
06/11/2025
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
06/11/2025
Announced expanded and accelerated Phase 3 Plan for CD388, its non-vaccine influenza preventative therapeutic Enrolled and dosed first patients in Phase 3 ANCHOR study; target enrollment on track for completion in the [...]
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
06/11/2025
- CX-2051 Phase 1 data update on track for Q1 2026 - - CX-2051 Phase 1b CRC combination study with bevacizumab to start in Q1 2026 - - Positive CX-801 Phase 1 monotherapy biomarker data at SITC 2025 supportive of [...]
Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History
06/11/2025
Third-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability SOUTH ORANGE, NJ., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: [...]
Omada Health Reports Third Quarter 2025 Results
06/11/2025
Revenue of $ 68 million, up 49% ; 53% Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE [...]

Pages